Oxford Investment Consultants LLP

What Oxford Investment Consultants LLP does

Oxford Investment Consultants LLP, operating as OTIF Ventures, is a UK FCA-regulated (Register number 807688) venture capital firm founded in 2015 and headquartered in Oxford. The firm manages the Oxford Technology and Innovations EIS Fund (OTIF), a tax-efficient Enterprise Investment Scheme vehicle that provides sophisticated and high-net-worth investors with access to early-stage, EIS-eligible spinout companies originating primarily from the University of Oxford, the University of Cambridge, and other world-leading UK research institutions. Sectors of focus are life sciences (therapeutics, medical devices, life science tools), deep tech (quantum computing, AI, advanced hardware), and physical sciences (materials, energy, advanced manufacturing). The firm has made over 150 investments since inception spanning Seed and follow-on through to Exit, with a track record that includes OrganOx's $1.5bn sale to Terumo in 2025.

The firm's underlying investment proposition combines preferential deal-flow access from deep university spinout ecosystems with active portfolio support, including board representation and strategic partnership, delivered by a team the firm describes as founders, investors, and scientists with specialist spinout experience. Notable portfolio companies include Caristo Diagnostics (FAI cardiac biomarker), Oxford Quantum Circuits (OQC), Oxford PV, and OrganOx. Distribution is direct and UK-focused: an Investor Portal on otif.vc, LinkedIn presence, and periodic London investor showcases convert sophisticated investors into fund LPs. Revenue is generated via recurring management fees on the EIS fund and carried interest on successful portfolio exits, and the firm rebranded from Oxford Investment Consultants to OTIF Ventures in April 2026 to unify its consumer-facing identity.

Name

Oxford Investment Consultants LLP

Legal name

Oxford Investment Consultants LLP

Website

https://oxfordinvestmentconsultants.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Oxford Investment Consultants LLP (OTIF Ventures) is a UK FCA-regulated venture capital firm managing the Oxford Technology and Innovations EIS Fund, investing in deep-science spinouts from Oxford, Cambridge, and other UK universities for sophisticated investors.

Ownership category

akta.pro rank

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Investment Management / Fund Management: OTIF Ventures manages the Oxford Technology and Innovations EIS Fund, providing sophisticated investors with access to early-stage, EIS-eligible university spinout companies. The firm generates revenue through investment management fees and carried interest on successful portfolio exits. Revenue is driven by long-term capital growth and portfolio diversification through the EIS tax-efficient structure.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Oxford Investment Consultants LLP (trading as OTIF Ventures) is a UK FCA-authorised investment management firm that manages the Oxford Technology and Innovations EIS Fund. The firm invests in early-stage, EIS-eligible university spinout companies from Oxford, Cambridge, and other world-leading UK research institutions, spanning Seed stage through follow-on rounds to Exit. It provides portfolio companies with active board-level support and strategic partnership alongside capital deployment.

Product overview

Oxford Investment Consultants LLP (now OTIF Ventures) is a venture capital firm offering a single unified investment platform through the Oxford Technology and Innovations EIS Fund. The firm provides early-stage investment services targeting university spinouts from Seed through to Exit, with active portfolio company support including board representation. They focus on three main sectors: Life Sciences (therapeutics, medical devices, life science tools), Deep Tech (quantum computing, AI, advanced hardware), and Physical Sciences (materials, energy, advanced manufacturing).

Differentiator

Problem solved

Functional benefit

Products and services

• Oxford Technology and Innovations EIS Fund (OTIF) An Enterprise Investment Scheme (EIS) fund that provides sophisticated investors with access to high-potential university spinout companies, targeting long-term capital growth and portfolio diversification through tax-efficient investments. The fund invests across Life Sciences, Deep Tech, and Physical Sciences sectors.
• Early-Stage Investment Services Investment services spanning Seed stage through follow-on rounds to Exit in early-stage university deep-science spinouts, with over 150 investments completed since the firm's founding in 2015.
• Portfolio Company Support Active support services for portfolio companies including board representation and strategic partnership to maximise value creation across invested university spinout companies.

Quantifiable outcome

• Over 150 investments in university deep-science spinouts with proven exits since 2015.
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• University of OxfordcoreStrategic or Co-development PartnerOTIF Ventures maintains a deep, strategic partnership with the University of Oxford's research ecosystem. The firm focuses on partnering with transformative companies originating from Oxford University, providing capital and active portfolio support. The deep integration within the university spinout ecosystem compounds knowledge, access, and long-term investment outcomes.
• University of CambridgecoreStrategic or Co-development PartnerOTIF Ventures invests in spinout companies from the University of Cambridge alongside Oxford. The firm explicitly states its focus on companies from Oxford and Cambridge as the primary university ecosystem for deal sourcing.
• Other UK Research InstitutionsminorStrategic or Co-development PartnerOTIF Ventures partners with companies from other world-leading UK research institutions beyond Oxford and Cambridge, expanding its deal sourcing network across the UK university ecosystem.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Oxford Science Enterprises (OSE): Oxford Science Enterprises is the largest dedicated investor in Oxford University spinouts, operating a long-duration partnership with the university. It is the most direct peer to OTIF Ventures given shared Oxford ecosystem, deep-science thesis, and sophisticated-LP base.
• Cambridge Innovation Capital (CIC): CIC is the dedicated investment vehicle for Cambridge University spinouts, mirroring OTIF's Oxford model in a parallel ecosystem. Highly comparable on thesis (deep-tech/life-sciences spinouts), LP profile, and university-embedded deal sourcing.
• Parkwalk Advisors: Parkwalk is a UK fund manager focused on university spinout investing via EIS and SEIS structures, targeting HNW/sophisticated investors. Highly comparable on the EIS vehicle structure and UK spinout thesis, with overlap on tax-efficient UK deep-tech exposure.
• Albion Capital: Albion Capital is a long-established UK fund manager running VCT and EIS products, with exposure to early-stage UK technology and life-sciences companies. Comparable as a UK EIS fund manager targeting sophisticated investors, though with a broader sector mandate.
• Maven Capital Partners: Maven (formerly Midven) is a UK fund manager running regional VCT/EIS mandates and investing in UK growth and early-stage companies. Comparable as a UK-based EIS/VCT manager targeting sophisticated investors, with overlap on EIS fund structures.
• IQ Capital: IQ Capital is a Cambridge-based deep-tech VC focused on early-stage UK deep-tech and life-sciences companies. Comparable on the Cambridge-adjacent deep-tech thesis and university-spinout deal flow, though without an explicit EIS fund wrapper.

Broad incumbents

• Octopus Ventures: Octopus Ventures is one of the largest UK VCs, operating EIS and VCT products alongside a broad early-stage portfolio. Comparable on the UK EIS distribution channel and HNW/sophisticated-investor base, but with a much broader sector mandate and scale.
• Amadeus Capital Partners: Amadeus is a UK deep-tech VC with a long history of investing in university-derived technology businesses across life sciences and deep tech. Comparable on deep-tech thesis and UK university spinout pipeline, though operating at broader institutional scale.

Emerging players

• Northern Gritstone: Northern Gritstone is a UK investment company focused on university spinouts and science-led businesses from northern English universities. Comparable on the university-spinout thesis and sophisticated-investor base, but operating in a different regional ecosystem.

Regional players

• FW Capital: FW Capital is a UK fund manager operating regional EIS/VCT mandates with exposure to early-stage UK businesses. Comparable on the UK EIS fund structure and early-stage mandate, but more regionally focused and less concentrated on deep-science spinouts.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/oxford-investment-consultants-llp
• Xx.com/avathemes
• Facebookfacebook.com/avapremiumthemes

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments25 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxford Investment Consultants LLP